Crossmark

Astrocyte Reprogramming Drives Tumor Progression and Chemotherapy Resistance in Agent-Based Models of Breast Cancer Brain Metastases

Published Online: 2025-12-02

Published Print: 2025-12

Authors

Kaur, Rupleen https://orcid.org/0000-0001-9170-3921
Barker-Clarke, Rowan

Dhawan, Andrew
Funding

Funding for this research was provided by:

National Institutes of Health (T32 GM007250, T32 GM152319, TL1 TR002549)

American Cancer Society (PF-24-1317034-01-HOPS)
License Information

Text and Data Mining valid from 2025-12-01

Version of Record valid from 2025-12-02
More Information

Article History

Received: 25 July 2025

Accepted: 27 October 2025

First Online: 2 December 2025

Declarations

:

: The authors declare that they have no conflict of interest.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current